Prediction for Critical Outcomes of Patients With COVID-19
Development and External Validation of a Prediction Model for Critical Outcomes of Patients With Confirmed COVID-19 in the Hospital Setting Based on Demographic Characteristics, Medical Conditions and Oral Health
1 other identifier
observational
600
1 country
2
Brief Summary
The study aims to develop and externally validate a prediction model for the critical outcomes of COVID-19 patients using predictors which can be easily obtained in clinical practice, including patients' demographic characteristics, self-reported medical conditions, and oral health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 17, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedNovember 18, 2021
November 1, 2021
3 months
November 17, 2021
November 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Critical outcomes of COVID-19
The critical outcomes include death, and ICU admission
March 2020 and May 2021
Study Arms (1)
Patients with confirmed COVID-19 in the hospital setting
Interventions
No intervention group
Eligibility Criteria
The patients were diagnosed as COVID-19 from the Isala Hospital (Zwolle, the Netherlands) or from Noordwest Ziekenhuis (NWZ) (Alkmaar, the Netherlands).
You may qualify if:
- patients who had a diagnosis of COVID-19 in the hospitals who visited the Department of Oral and Maxillofacial Surgery (OMFS) between March 2020 and May 2021, if they have had a dental panoramic radiograph (OPG), obtained up to a maximum of 5 years until the end of the current study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Noordwest Ziekenhuis (NWZ)
Alkmaar, Netherlands
Isala Hospital
Zwolle, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
November 17, 2021
First Posted
November 18, 2021
Study Start
September 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
November 18, 2021
Record last verified: 2021-11